Search research articles
Contact Us
Filters
Showing results (401-410 of 462) with videos related to
Page
of 47
Sort By:
Mutation Research. Genetic Toxicology and Environmental Mutagenesis
|
October 4, 2016
Standardized cell sources and recommendations for good cell culture practices in genotoxicity testing
E Lorge, M M Moore, J Clements, et al.
ACR Open Rheumatology
|
December 5, 2020
Racial Disparities in Systemic Sclerosis: Short- and Long-Term Outcomes Among African American Participants of SLS I and II
Elizabeth R Volkmann, Virginia Steen, Ning Li, et al.
Chemical Research in Toxicology
|
October 24, 2018
Information-Derived Mechanistic Hypotheses for Structural Cardiotoxicity
Fredrik Svensson, Azedine Zoufir, Samar Mahmoud, et al.
Clinical Chemistry
|
November 9, 2000
New nomenclature for the human tissue kallikrein gene family
E P Diamandis, G M Yousef, J Clements, et al.
The Journal of Rheumatology
|
February 17, 2019
Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II
Elizabeth R Volkmann, Donald P Tashkin, Myung Sim, et al.
ACS Chemical Biology
|
February 5, 2014
De novo design of self-assembling foldamers that inhibit heparin-protein interactions
Geronda L Montalvo, Yao Zhang, Trevor M Young, et al.
Scientific Reports
|
November 26, 2022
Joint analysis of structured and semi-structured community science data improves precision of relative abundance but not trends in birds
Alexander R Schindler, Stephanie A Cunningham, Toryn L J Schafer, et al.
Annals of the Rheumatic Diseases
|
September 26, 2007
Development of a provisional core set of response measures for clinical trials of systemic sclerosis
D Khanna, D J Lovell, E Giannini, et al.
Mutagenesis
|
May 13, 2010
Development and characterization of an in vivo skin photomicronucleus assay in rats
Astrid A Reus, Mustafa Usta, Richard N C van Meeuwen, et al.
Seminars in Arthritis and Rheumatism
|
September 9, 2020
The MUC5B promoter variant does not predict progression of interstitial lung disease in systemic sclerosis
Elizabeth R Volkmann, Donald P Tashkin, Michael D Roth, et al.
Page
of 47
Search research articles
Search
Showing results (401-410 of 462) with videos related to
Sort By:
Page
of 47
Mutation Research. Genetic Toxicology and Environmental Mutagenesis
|
October 4, 2016
Standardized cell sources and recommendations for good cell culture practices in genotoxicity testing
E Lorge, M M Moore, J Clements, et al.
ACR Open Rheumatology
|
December 5, 2020
Racial Disparities in Systemic Sclerosis: Short- and Long-Term Outcomes Among African American Participants of SLS I and II
Elizabeth R Volkmann, Virginia Steen, Ning Li, et al.
Chemical Research in Toxicology
|
October 24, 2018
Information-Derived Mechanistic Hypotheses for Structural Cardiotoxicity
Fredrik Svensson, Azedine Zoufir, Samar Mahmoud, et al.
Clinical Chemistry
|
November 9, 2000
New nomenclature for the human tissue kallikrein gene family
E P Diamandis, G M Yousef, J Clements, et al.
The Journal of Rheumatology
|
February 17, 2019
Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II
Elizabeth R Volkmann, Donald P Tashkin, Myung Sim, et al.
ACS Chemical Biology
|
February 5, 2014
De novo design of self-assembling foldamers that inhibit heparin-protein interactions
Geronda L Montalvo, Yao Zhang, Trevor M Young, et al.
Scientific Reports
|
November 26, 2022
Joint analysis of structured and semi-structured community science data improves precision of relative abundance but not trends in birds
Alexander R Schindler, Stephanie A Cunningham, Toryn L J Schafer, et al.
Annals of the Rheumatic Diseases
|
September 26, 2007
Development of a provisional core set of response measures for clinical trials of systemic sclerosis
D Khanna, D J Lovell, E Giannini, et al.
Mutagenesis
|
May 13, 2010
Development and characterization of an in vivo skin photomicronucleus assay in rats
Astrid A Reus, Mustafa Usta, Richard N C van Meeuwen, et al.
Seminars in Arthritis and Rheumatism
|
September 9, 2020
The MUC5B promoter variant does not predict progression of interstitial lung disease in systemic sclerosis
Elizabeth R Volkmann, Donald P Tashkin, Michael D Roth, et al.
Page
of 47